Incannex Healthcare Limit...

NASDAQ: IXHL · Real-Time Price · USD
0.39
-0.19 (-33.33%)
At close: Aug 01, 2025, 3:59 PM

Incannex Healthcare Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 29, 2023 Jun 30, 2023 Mar 30, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
n/a 12K 74K 12K n/a n/a n/a n/a n/a n/a n/a 270.08K 292.74K n/a n/a 270.11K 273.62K 453.8K 421.38K
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a 54.31K n/a 33.85K n/a 57.98K 62.84K 63.32K 62.98K 140.23K 142.05K 207.38K 192.56K
Gross Profit
n/a 12K 74K 12K n/a n/a n/a n/a n/a n/a n/a 212.11K 355.59K -63.32K -62.98K 129.88K 131.56K 246.42K 228.82K
Operating Income
-5M -5M -6.25M -9.74M -7.42M -7.98M -4.89M -4.19M -3.65M -3.64M -20.91M -2.43M -2.63M -1.69M -1.68M -2.41M -2.44M -1.46M -1.35M
Interest Income
4K 28K 28K 40K 75K 20K 71K 87.13K 163K 55K 26K 3.86K n/a 662.05 n/a n/a n/a 1.38K n/a
Pretax Income
-3.97M -5.89M -5.42M -6.43M -6.03M -5.24M -726K -4.17M -3.57M -2.92M -20.53M -3.33M -3.61M -1.91M -1.9M -2.83M -2.87M -1.47M -1.37M
Net Income
-3.97M -5.89M -5.42M -6.46M -6.03M -5.24M -726K -4.17M -3.57M -2.92M -20.53M -3.33M -3.61M -1.91M -1.9M -2.83M -2.87M -1.47M -1.37M
Selling & General & Admin
2.27M 3.6M 3.43M 5.29M 4.14M 5.34M 2.28M 2.32M 2.01M 2.09M 1.76M 1.61M 1.75M 757.02K 752.92K 1.53M 1.55M 919.25K 853.57K
Research & Development
2.73M 1.41M 2.9M 4.36M 3.28M 2.64M 2.61M 1.6M 1.64M 1.55M 19.15M 1.02M 1.11M 872.46K 867.73K 1.02M 1.03M 786.1K 729.93K
Other Expenses
n/a n/a n/a 103K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
5M 5.02M 6.33M 9.76M 7.42M 7.98M 4.89M 4.19M 3.65M 3.64M 20.91M 2.64M 2.86M 1.63M 1.62M 2.54M 2.58M 1.71M 1.58M
Interest Expense
132K 171K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 643.60 n/a
Selling & Marketing Expenses
n/a n/a n/a 1.05M n/a n/a n/a 1.23M n/a n/a 17.5K 655.29K 710.27K 308.06K 306.39K 1.54M 1.56M 87.71K 81.45K
Cost & Expenses
5M 5.02M 6.33M 9.76M 7.42M 7.98M 4.89M 4.19M 3.65M 3.64M 20.91M 2.7M 2.92M 1.69M 1.68M 2.68M 2.72M 1.91M 1.78M
Income Tax Expense
n/a n/a n/a 30K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
19.63M 17.62M 17.64M 17.04M 15.87M 15.87M 15.87M 15.63M 15.87M 15.4M 14.9M 308.63M 308.63M 286.95M 279.01M 262.97M 262.97M 225.53M 225.53M
Shares Outstanding (Diluted)
19.63M 17.62M 17.64M 17.04M 15.87M 15.87M 15.87M 15.63M 15.87M 15.4M 14.9M 308.62M 308.62M 286.95M 286.95M 262.95M 262.95M 225.51M 225.51M
EPS (Basic)
-0.2 -0.33 -0.29 -0.38 -0.38 -0.33 -0.08 -0.27 -0.22 -0.19 -1.38 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01
EPS (Diluted)
-0.2 -0.33 -0.29 -0.38 -0.38 -0.33 -0.08 -0.27 -0.22 -0.19 -1.38 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01
EBITDA
-3.84M -5.6M -5.38M -6.4M -6.01M -5.24M -783K -4.19M -3.73M -2.96M -2.88M n/a n/a n/a n/a n/a n/a n/a n/a
EBIT
-4.58M -5.72M -5.44M -6.46M -6.09M -5.26M -795K -4.02M -3.73M -2.97M -2.9M -2.31M -2.5M -1.69M -1.68M -2.4M -2.43M -1.46M -1.35M
Depreciation & Amortization
-5K 126K 64K 62K 17K 12K 12K 54.31K 7.33K 17.5K 17.5K 2.31M 2.5M 1.69M 1.68M 2.4M 2.43M 1.46M 1.35M